Town & Country Bank & Trust CO dba First Bankers Trust CO increased its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 22.3% in the second quarter, Holdings Channel reports. The firm owned 2,993 shares of the company’s stock after acquiring an additional 545 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in McKesson were worth $2,193,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC acquired a new stake in shares of McKesson in the fourth quarter valued at about $26,000. Bank of Jackson Hole Trust boosted its holdings in McKesson by 64.3% in the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company’s stock worth $29,000 after acquiring an additional 18 shares during the period. CBIZ Investment Advisory Services LLC grew its position in McKesson by 1,366.7% in the first quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company’s stock valued at $30,000 after acquiring an additional 41 shares in the last quarter. Saudi Central Bank purchased a new stake in shares of McKesson during the first quarter valued at approximately $34,000. Finally, Flaharty Asset Management LLC acquired a new position in shares of McKesson during the first quarter worth $39,000. 85.07% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total value of $218,347.43. Following the completion of the sale, the chief accounting officer owned 657 shares of the company’s stock, valued at $436,031.19. This represents a 33.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 19,371 shares of the business’s stock in a transaction dated Friday, July 11th. The stock was sold at an average price of $708.09, for a total transaction of $13,716,411.39. Following the sale, the chief executive officer owned 27,872 shares in the company, valued at $19,735,884.48. This trade represents a 41.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,560 shares of company stock valued at $30,438,602. 0.08% of the stock is owned by insiders.
McKesson Price Performance
McKesson (NYSE:MCK – Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.33 by ($0.07). McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The company had revenue of $97.83 billion during the quarter, compared to the consensus estimate of $95.93 billion. During the same quarter in the previous year, the business posted $7.88 earnings per share. The business’s quarterly revenue was up 23.4% compared to the same quarter last year. As a group, research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.
McKesson Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 2nd. This is a positive change from McKesson’s previous quarterly dividend of $0.71. McKesson’s dividend payout ratio (DPR) is presently 13.08%.
Analysts Set New Price Targets
MCK has been the subject of a number of recent analyst reports. Wells Fargo & Company raised their price target on shares of McKesson from $766.00 to $772.00 and gave the company an “equal weight” rating in a report on Wednesday, August 13th. Morgan Stanley reaffirmed an “overweight” rating and set a $810.00 target price (up from $770.00) on shares of McKesson in a research report on Wednesday, July 16th. Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a research note on Saturday. Cowen restated a “buy” rating on shares of McKesson in a research note on Thursday, August 7th. Finally, Evercore ISI lifted their price objective on McKesson from $760.00 to $800.00 and gave the stock an “outperform” rating in a report on Wednesday, July 9th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus target price of $725.10.
Get Our Latest Stock Report on McKesson
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Stories
- Five stocks we like better than McKesson
- What is the Nasdaq? Complete Overview with History
- How The Weak Dollar Is Fueling These Global Stock Surges
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- Consumer Staples Stocks, Explained
- 3 Automation-Focused Stocks Flying Under the Radar
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.